Marketocracy Bets on Medical Imaging
11/22/2002 12:00 am EST
Marketocracy allows thousands of individuals to create and monitor their own mutual fund portfolios. The 100 best performing "fund mangers" are then compiled into the m100. From their buys and sells, Ken Kam manages an actual mutual fund, which has outperformed the S&P 500 by 13.6 percentage points over the past year. The latest top buy from the m100 is a biotech-imaging company.
"Analogic Corp. (
"Analogic, a manufacturer of medical imaging and data acquisition systems, is already profitable with EBITDA of $16.2 million over the last 12 months. And though the company's p/e is north of 170, it is important to note that earnings in the most recent quarter were nearly five times larger than the same period a year ago. With earnings growing at such an aggressive clip, the P/E becomes a less meaningful measure, ill-equipped to value Analogic's future earnings growth potential."